MaxCyte, Inc. (MXCT)
USD 2.6
(-5.8%)
USD 2.6
(-5.8%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 41.28 Million USD | -6.72% |
| 2022 | 44.26 Million USD | 30.59% |
| 2021 | 33.89 Million USD | 29.52% |
| 2020 | 26.16 Million USD | 21.04% |
| 2019 | 21.62 Million USD | 29.72% |
| 2018 | 16.66 Million USD | 19.18% |
| 2017 | 13.98 Million USD | 13.98% |
| 2016 | 12.26 Million USD | 32.07% |
| 2015 | 9.29 Million USD | 29.67% |
| 2014 | 7.16 Million USD | 5.28% |
| 2013 | 6.8 Million USD | 34.5% |
| 2012 | 5.05 Million USD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 10.42 Million USD | -8.05% |
| 2024 Q1 | 11.34 Million USD | -27.6% |
| 2023 Q2 | 9.04 Million USD | 5.44% |
| 2023 Q3 | 8 Million USD | -11.48% |
| 2023 Q1 | 8.57 Million USD | -30.97% |
| 2023 Q4 | 15.66 Million USD | 95.71% |
| 2023 FY | 41.28 Million USD | -6.72% |
| 2022 Q4 | 12.42 Million USD | 16.73% |
| 2022 Q3 | 10.64 Million USD | 10.77% |
| 2022 Q2 | 9.6 Million USD | -17.08% |
| 2022 FY | 44.26 Million USD | 30.59% |
| 2022 Q1 | 11.58 Million USD | 14.14% |
| 2021 Q4 | 10.15 Million USD | 0.13% |
| 2021 FY | 33.89 Million USD | 29.52% |
| 2021 Q2 | 7.1 Million USD | 9.44% |
| 2021 Q3 | 10.13 Million USD | 42.64% |
| 2021 Q1 | 6.49 Million USD | -23.72% |
| 2020 FY | 26.16 Million USD | 21.04% |
| 2020 Q3 | 6.76 Million USD | 31.3% |
| 2020 Q4 | 8.51 Million USD | 25.9% |
| 2020 Q2 | 5.15 Million USD | -10.3% |
| 2020 Q1 | 5.74 Million USD | -13.31% |
| 2019 Q4 | 6.62 Million USD | 0.0% |
| 2019 FY | 21.62 Million USD | 29.72% |
| 2019 Q3 | 6.62 Million USD | 58.21% |
| 2019 Q2 | 4.18 Million USD | 0.0% |
| 2019 Q1 | 4.18 Million USD | -14.01% |
| 2018 Q4 | 4.86 Million USD | 0.0% |
| 2018 FY | 16.66 Million USD | 19.18% |
| 2018 Q2 | 3.46 Million USD | 0.0% |
| 2018 Q3 | 4.86 Million USD | 40.51% |
| 2018 Q1 | 3.46 Million USD | -10.87% |
| 2017 Q1 | 3.1 Million USD | -8.71% |
| 2017 Q2 | 3.1 Million USD | 0.0% |
| 2017 Q4 | 3.88 Million USD | 0.0% |
| 2017 Q3 | 3.88 Million USD | 25.2% |
| 2017 FY | 13.98 Million USD | 13.98% |
| 2016 Q1 | 2.73 Million USD | 7.34% |
| 2016 FY | 12.26 Million USD | 32.07% |
| 2016 Q4 | 3.4 Million USD | 0.0% |
| 2016 Q3 | 3.4 Million USD | 24.42% |
| 2016 Q2 | 2.73 Million USD | 0.0% |
| 2015 Q3 | 2.54 Million USD | 21.35% |
| 2015 Q2 | 2.09 Million USD | 0.0% |
| 2015 Q1 | 2.09 Million USD | -0.19% |
| 2015 FY | 9.29 Million USD | 29.67% |
| 2015 Q4 | 2.54 Million USD | 0.0% |
| 2014 FY | 7.16 Million USD | 5.28% |
| 2014 Q4 | 2.1 Million USD | 0.0% |
| 2014 Q1 | 1.47 Million USD | 0.0% |
| 2014 Q2 | 1.47 Million USD | 0.0% |
| 2014 Q3 | 2.1 Million USD | 42.08% |
| 2013 FY | 6.8 Million USD | 34.5% |
| 2012 FY | 5.05 Million USD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Acutus Medical, Inc. | 7.16 Million USD | -476.326% |
| Cerus Corporation | 156.36 Million USD | 73.595% |
| OrthoPediatrics Corp. | 148.73 Million USD | 72.24% |
| PetVivo Holdings, Inc. | 968.7 Thousand USD | -4162.181% |
| Talis Biomedical Corporation | 412 Thousand USD | -9921.359% |
| Vivos Therapeutics, Inc. | 13.8 Million USD | -199.167% |
| Inogen, Inc. | 315.66 Million USD | 86.92% |
| Spectral AI, Inc. | 18.05 Million USD | -128.666% |
| Nano-X Imaging Ltd. | 9.9 Million USD | -316.84% |
| CVRx, Inc. | 39.29 Million USD | -5.072% |
| DIH Holding US, Inc. Warrants | - USD | -Infinity% |
| Helius Medical Technologies, Inc. | 644 Thousand USD | -6311.18% |
| Orthofix Medical Inc. | 746.64 Million USD | 94.47% |
| Venus Concept Inc. | 76.35 Million USD | 45.926% |
| Accelerate Diagnostics, Inc. | 12.05 Million USD | -242.383% |
| Bioventus Inc. | 512.34 Million USD | 91.941% |
| BrainsWay Ltd. | 31.78 Million USD | -29.898% |
| Envoy Medical, Inc. | 316 Thousand USD | -12965.823% |
| electroCore, Inc. | 16.03 Million USD | -157.567% |
| IceCure Medical Ltd | 3.22 Million USD | -1178.662% |
| Lucid Diagnostics Inc. | 2.42 Million USD | -1600.494% |
| Monogram Orthopaedics, Inc. | 364.99 Thousand USD | -11211.812% |
| NeuroOne Medical Technologies Corporation | 1.95 Million USD | -2014.686% |
| Nexalin Technology, Inc. | 110.74 Thousand USD | -37181.034% |
| PAVmed Inc | 2.45 Million USD | -1583.85% |
| Rapid Micro Biosystems, Inc. | 22.51 Million USD | -83.347% |
| RxSight, Inc. | 89.07 Million USD | 53.649% |
| Sight Sciences, Inc. | 81.05 Million USD | 49.062% |
| SI-BONE, Inc. | 138.88 Million USD | 70.272% |
| TELA Bio, Inc. | 58.45 Million USD | 29.365% |
| TriSalus Life Sciences, Inc. | 18.51 Million USD | -123.046% |
| Treace Medical Concepts, Inc. | 187.11 Million USD | 77.935% |
| LivaNova PLC | 1.15 Billion USD | 96.421% |
| 908 Devices Inc. | 50.22 Million USD | 17.8% |
| Alphatec Holdings, Inc. | 482.26 Million USD | 91.439% |
| Nemaura Medical Inc. | 77.04 Thousand USD | -53490.156% |
| NeuroPace, Inc. | 65.42 Million USD | 36.889% |
| LENSAR, Inc. | 42.16 Million USD | 2.078% |
| Apyx Medical Corporation | 52.34 Million USD | 21.129% |
| Cutera, Inc. | 212.36 Million USD | 80.558% |
| STRATA Skin Sciences, Inc. | 33.35 Million USD | -23.772% |
| BioSig Technologies, Inc. | 18 Thousand USD | -229277.778% |
| Anika Therapeutics, Inc. | 166.66 Million USD | 75.227% |
| ClearPoint Neuro, Inc. | 23.95 Million USD | -72.357% |
| Integra LifeSciences Holdings Corporation | 1.54 Billion USD | 97.322% |
| Axonics, Inc. | 366.37 Million USD | 88.731% |
| Outset Medical, Inc. | 130.37 Million USD | 68.332% |
| IRIDEX Corporation | 51.86 Million USD | 20.399% |
| PROCEPT BioRobotics Corporation | 136.19 Million USD | 69.684% |
| IRadimed Corporation | 65.56 Million USD | 37.025% |
| Tivic Health Systems, Inc. | 1.17 Million USD | -3410.884% |
| INVO Bioscience, Inc. | 3.02 Million USD | -1266.892% |
| Telesis Bio, Inc. | 27.5 Million USD | -50.089% |
| Viemed Healthcare, Inc. | 183 Million USD | 77.439% |
| Varex Imaging Corporation | 811 Million USD | 94.909% |
| Quipt Home Medical Corp. | 221.74 Million USD | 81.38% |
| Inspira Technologies Oxy B.H.N. Ltd. | - USD | -Infinity% |
| Pulmonx Corporation | 68.67 Million USD | 39.879% |
| Dynatronics Corporation | 32.53 Million USD | -26.907% |
| Modular Medical, Inc. | - USD | -Infinity% |
| ReShape Lifesciences Inc. | 8.67 Million USD | -375.778% |
| Semler Scientific, Inc. | 68.18 Million USD | 39.446% |
| InMode Ltd. | 492.04 Million USD | 91.609% |
| Bruker Corporation | 2.96 Billion USD | 98.607% |
| Cytosorbents Corporation | 36.34 Million USD | -13.587% |
| DexCom, Inc. | 3.62 Billion USD | 98.86% |
| Align Technology, Inc. | 3.86 Billion USD | 98.931% |
| Viveve Medical, Inc. | 6.42 Million USD | -542.515% |
| ZimVie Inc. | 457.43 Million USD | 90.974% |
| Movano Inc. | - USD | -Infinity% |
| Cytek Biosciences, Inc. | 193.01 Million USD | 78.609% |
| Nexalin Technology, Inc. | 110.74 Thousand USD | -37181.034% |
| DIH Holdings US, Inc. Class A Common Stock | - USD | -Infinity% |
| Tandem Diabetes Care, Inc. | 747.71 Million USD | 94.478% |
| Profound Medical Corp. | 7.33 Million USD | -463.196% |
| Insulet Corporation | 1.69 Billion USD | 97.567% |
| enVVeno Medical Corporation | - USD | -Infinity% |
| Surmodics, Inc. | 126.07 Million USD | 67.252% |
| iCAD, Inc. | 17.31 Million USD | -138.411% |
| Nuwellis, Inc. | 8.86 Million USD | -365.794% |
| Biotricity, Inc. | 12.06 Million USD | -242.26% |
| iRhythm Technologies, Inc. | 492.68 Million USD | 91.62% |
| Aethlon Medical, Inc. | - USD | -Infinity% |
| InspireMD, Inc. | 6.2 Million USD | -565.399% |
| PAVmed Inc. | 2.45 Million USD | -1583.85% |
| BIOLASE, Inc. | 49.16 Million USD | 16.02% |
| Beyond Air, Inc. | 1.15 Million USD | -3462.381% |
| FONAR Corporation | 102.88 Million USD | 59.869% |
| AxoGen, Inc. | 159.01 Million USD | 74.035% |
| Vivani Medical, Inc. | - USD | -Infinity% |
| Tactile Systems Technology, Inc. | 274.42 Million USD | 84.955% |
| Inari Medical, Inc. | 493.63 Million USD | 91.636% |
| UFP Technologies, Inc. | 400.07 Million USD | 89.68% |
| QT Imaging Holdings, Inc. | - USD | -Infinity% |
| Heart Test Laboratories, Inc. | 18.6 Thousand USD | -221878.495% |
| Tenon Medical, Inc. | 2.92 Million USD | -1310.109% |
| Autonomix Medical, Inc. Common Stock | - USD | -Infinity% |
| Co-Diagnostics, Inc. | 6.81 Million USD | -506.103% |
| AdaptHealth Corp. | 3.2 Billion USD | 98.71% |
| Sintx Technologies, Inc. | 2.62 Million USD | -1471.679% |
| NanoVibronix, Inc. | 2.28 Million USD | -1708.498% |
| Quanterix Corporation | 122.36 Million USD | 66.259% |
| Inspira Technologies Oxy B.H.N. Ltd. | - USD | -Infinity% |
| Sensus Healthcare, Inc. | 24.4 Million USD | -69.178% |
| Pacific Biosciences of California, Inc. | 200.52 Million USD | 79.41% |
| TransMedics Group, Inc. | 241.62 Million USD | 82.912% |
| ReWalk Robotics Ltd. | 13.85 Million USD | -198.022% |
| NeuroMetrix, Inc. | 5.9 Million USD | -599.628% |
| Hyperfine, Inc. | 11.03 Million USD | -274.257% |
| Establishment Labs Holdings Inc. | 165.15 Million USD | 75.0% |
| Biomerica, Inc. | 5.41 Million USD | -662.475% |
| Bone Biologics Corporation | - USD | -Infinity% |
| AVITA Medical, Inc. | 50.56 Million USD | 18.34% |
| Bluejay Diagnostics, Inc. | - USD | -Infinity% |
| Silk Road Medical, Inc | 177.13 Million USD | 76.691% |